Cerus to Present at the Baird 2015 Healthcare Conference on September 9, 2015

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ: CERS) announced today that Kevin Green, Cerus’ vice president and chief financial officer, is scheduled to present a corporate update at the Baird 2015 Healthcare Conference at 3:45 PM ET on Wednesday, September 9, 2015.

A live webcast of the presentation will be available from the Investor Relations page of the Cerus web site at http://www.cerus.com/ir. A replay will be available for approximately two weeks following the completion of the event.

ABOUT CERUS

Cerus Corporation is a biomedical products company focused in the field of blood safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development. See http://www.cerus.com for information about Cerus.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150902005015/en/

Investor Relations Contacts:
Cerus Corporation
Stacey Leanos, 925-288-6137
Associate Director, Investor & Public Relations
[email protected]
Lainie Corten, 925-288-6137
Vice President, Global Marketing & Investor Relations
[email protected]

Source: Cerus Corporation

You May Also Be Interested In

• Business growth stunted by manual tasks, Tipalti study finds
• TraWell Co Conducts Sustainability Assessment With Cerved Rating Agency
• Harju Elekter Group financial results, 1-3/2024